This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Developing Individualized Asthma Action Plans for the Severe Uncontrolled Patient in an Era of Targeted Therapy

Developing Individualized Asthma Action Plans for the Severe Uncontrolled Patient in an Era of Targeted Therapy

Format

Roundtable

Time to Complete

2 hours

Released

May 15, 2017

Expires

May 15, 2018
Add to Queue


Maximum Credits

2.00 / AMA PRA Category 1 CreditsTM
2.00 / AANP Contact Hours

Accredited Provider

Jointly provided by Global Education Group and Physicians' Education Resource®, LLC (PER®)

Commercial Supporter

Supported by an educational grant from Novartis Pharmaceuticals Corporation

Program Description

In recent years, uncontrolled asthma has been recognized to be a heterogeneous syndrome with different underlying pathophysiological features. Efforts to define key drivers for asthma “phenotypes” have focused on the role of eosinophilic inflammation and Th2 type immunological pathways, and led to the clinical development of biologics that antagonize IL-5, IL-4, and IL-13 pathways. With the availability of three biologics for asthma treatment and several other biologics in clinical development, it is imperative that all clinicians be trained on the stepwise approach to asthma treatment described in the guidelines as well as on these novel treatment options so they are able to individualize treatment and optimize patient outcomes.

During this Medical Crossfire, expert faculty will engage in a multidisciplinary roundtable discussion that includes a pulmonologist, primary care clinician, nurse practitioner and a patient advocate to discuss how to best optimize and individualize asthma management. A focus will be placed on managing the severe, uncontrolled asthma patient.

Intended Audience

Physicians, nurses, nurse practitioners, and physician assistants

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Articulate the importance of providing self-management education and asthma action plan (AAP) to asthma patients
  • Appropriately evaluate patients with asthma for level of control, asthma severity, and risk of exacerbations
  • Explore the current guidelines for asthma treatment
  • Differentiate between the different biologics based on mechanism of action and phenotypes
  • Describe how to make individualized treatment selections in patients with uncontrolled asthma that appropriately address the impact of underlying inflammation

Faculty

Peter Salgo, MD
Professor of Medicine and Anesthesiology
Columbia University College of Physicians and Surgeons
New York, NY

Dr. Salgo has no relevant financial relationships with commercial interests to disclose.

Natasha McClure, DNP, RN, CPNP
Instructor
Vanderbilt University School of Nursing
Nashville, TN

Dr. McClure has no relevant financial relationships with commercial interests to disclose.

Michael E. Wechsler, MD
Professor of Medicine
Director, Asthma Program
Co-Director, Cohen Family NJH Asthma Institute
National Jewish Health
Denver, CO

Dr. Wechsler has the following relevant financial relationships with commercial interest to disclose:
Grant/Research Support: Sanofi/Regeneron
Consultant: AstraZeneca, Teva, Boston Scientific, Boehringer Ingelheim, Genentech, Viatris, and Gliacure

Mark Titus
Patient Advocate
Clinton Township, MI

Mr. Titus has no relevant financial relationships with commercial interests to disclose.

Accredited Provider Disclosure

Kristen Delisi, NP, Lindsay Borvansky, Andrea Funk, and Laura Gilsdorf have no relevant financial relationships with commercial interests to disclose

Publishing Staff Disclosures

Physicians' Education Resource®, LLC (PER®)
Planning Staff: Dave Heckard, Maryjo Dixon, RPh, Donna Fausak, and Nicole Grassano have no relevant financial relationships with commercial interests to disclose.

Credit

2.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians' Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring activity for a maximum of 2.00 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

2.00

Type

CE for Nurse Practitioners

Accreditation Statement


Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121

Designation Statement

This activity is accredited for 2.00 contact hour(s) which includes 0.00 hour(s) of pharmacology.

Activity ID #2304E

This activity was planned in accordance with AANP CE Standards and Policies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

There is no fee for this educational activity.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue